Fiona Maclean

Fiona Maclean

Auto-generated profile, based on publicly available information

Fiona Maclean

Douglass Hanly Moir Pathology, Macquarie Park, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 March 2025 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
ASAnkur R. Sangoi
Ankur R. Sangoi
SWSean Williamson
Sean Williamson
MOMurat Oktay
Murat Oktay
AGAnthony J. Gill
Anthony J. Gill
Kiril TrpkovKiril Trpkov
Kiril Trpkov
MAMahmut Akgul
Mahmut Akgul

13 May 2025 in Histopathology
Verified
Journal Article
Open access
MNMahra Nourbakshs
Mahra Nourbakshs
LDLiping Du
Liping Du
AAAndres Martin Acosta
Andres Martin Acosta
RAReza Alaghehbandan
Reza Alaghehbandan
AAAli Amin
Ali Amin
GGGiovanna A Giannico
Giovanna A Giannico
Aims: Standardizing pathology reporting protocols through peer consensus review is critical for the best quality of care metrics. Reporting heterogeneity due to discrepancies among professional societies and practice patterns may lead to heterogeneous management and treatment approaches. This issue prompted a multi‐institutional survey of pathologists to address potential similarities or differences in trends and practice patterns in prostate pathology reporting worldwide.Methods and Results: A REDCap survey was distributed among 175 pathologists worldwide, recruited through invitations and social media. The response rate among invited pathologists was 83%. The practice locations were as follows: North America (USA, Canada, and Mexico, 62%), Europe (17%), Australia/New Zealand (3%), Central/South America (2%), Asia (13%), and Africa (2%). Most pathologists practiced for <5 years (28%). A genitourinary (GU) pathology fellowship was completed by 37%, 58% practiced in a subspecialized setting, and 43% in academia. Reporting includes (63%) or subtracts (37%) intervening benign tissue. Both Gleason score and Grade Groups (GG)s were reported by 96% of responders, whereas 94% report percent pattern 4 (%4). Aggregate grading and volume estimation in undesignated cores with different grades in the same jar are reported by 73% and 54% for systematic biopsies, and 83% and 62% for targeted biopsies, respectively. Cribriform morphology was reported by 81%. For presumed intraductal carcinoma (IDC), 89% use basal cell markers when isolated (iIDC), 82% with GG1 cancer, and 37% with ≥GG2. iIDC or IDC associated with GG1 or with ≥GG2 was not graded by 90%, 78%, and 70%, respectively. In radical prostatectomies, 90% report %4, but only 53% report it if the overall grade is ≥7. A tumour with Gleason 3 + 3 = 6 and <5% pattern 4 was graded as GG2 by 64%. A 5% pattern 4 or 5 as a secondary pattern. Grading was assigned based on the dominant nodule by 59%. Finally, reporting practices were significantly associated with demographic characteristics.Conclusions: Although most issues are agreed upon, significant discordance is identified among societies and pathologists in different practice settings. We hope this survey will serve as the basis for future studies and new collaborative approaches to more standardized reporting practices.

1 June 2020 in Pathology
Verified
Journal Article
Closed access
RKRoger H. Kim
Roger H. Kim
ALAnna Lapuk
Anna Lapuk
JHJames Harraway
James Harraway
ELEric Lee
Eric Lee
MWMichael Walsh
Michael Walsh
AVAna Cristina Vargas
Ana Cristina Vargas

16 July 2025 in Histopathology
Verified
Journal Article
Closed access
WAWilliam Anderson
William Anderson
DKDavid Kolin
David Kolin
IGIvan A Gonzalez
Ivan A Gonzalez
SVSara Vargas
Sara Vargas
PGPilar Gonzalez‐Peramato
Pilar Gonzalez‐Peramato
AAAndres Martin Acosta
Andres Martin Acosta

25 July 2023 in Pathology
Verified
Journal Article
Closed access
CMCatriona A. McKenzie
Catriona A. McKenzie
RGRuta Gupta
Ruta Gupta
LJLouise Jackett
Louise Jackett
LALyndal Anderson
Lyndal Anderson
VCVivien Chen
Vivien Chen
WCWendy Cooper
Wendy Cooper